Successful COVID-19 Elimination After an Alpha Variant Outbreak in a "safe Travel Zone"

Overview

Journal Travel Med Infect Dis

Specialty Infectious Diseases

Date 2021 Nov 12

PMID 34767909

Citations 3

Authors

Pierre-Henri Moury

Ann-Claire Gourinat

Olivier Riou

Sylvie Laumond

Myrielle Dupont-Rouzeyrol

Cecile Cazorla

Morgan Mangeas

Affiliations

Soon will be listed here.

Citing Articles

Colonial transition as a major mediator of global health transition: lessons from the 2024 New Caledonia crisis.

Moury P, Tromhae M, Cazorla C, Serie M, Flahault A, Couadau E J Glob Health. 2025; 15:03004.

PMID: 39883876 PMC: 11781806. DOI: 10.7189/jogh.15.03004.

A seroprevalence study of SARS-CoV-2 and seasonal coronaviruses after the first SARS-CoV-2 circulation in New Caledonia, Pacific region.

Huet K, White M, Griffon A, Bloch E, Magnat E, Baudemont G IJID Reg. 2024; 11:100373.

PMID: 38799796 PMC: 11127231. DOI: 10.1016/j.ijregi.2024.100373.

Evaluating the strategies to control SARS-CoV-2 Delta variant spread in New Caledonia, a zero-COVID country until September 2021.

Ochida N, Dupont-Rouzeyrol M, Moury P, Demaneuf T, Gourinat A, Mabon S IJID Reg. 2023; 8:64-70.

PMID: 37583482 PMC: 10423666. DOI: 10.1016/j.ijregi.2023.06.004.

Impact of lockdown on cardiovascular disease hospitalizations in a Zero-COVID-19 country.

Moury P, Ochida N, Motiejunaite J, Collart V, Serie M, Gervolino S Public Health. 2023; 217:98-104.

PMID: 36867989 PMC: 9894760. DOI: 10.1016/j.puhe.2023.01.029.

References

McAnulty J, Ward K . Suppressing the Epidemic in New South Wales. N Engl J Med. 2020; 382(21):e74. PMC: 7233304. DOI: 10.1056/NEJMc2011592. View

Kerbaj J, Cazorla C, De Greslan T, Serie M, Gourinat A, Marot B . COVID-19: The New Caledonia Experience. Clin Infect Dis. 2020; 71(16):2279-2281. PMC: 7239214. DOI: 10.1093/cid/ciaa600. View

Baker M, Wilson N, Anglemyer A . Successful Elimination of Covid-19 Transmission in New Zealand. N Engl J Med. 2020; 383(8):e56. PMC: 7449141. DOI: 10.1056/NEJMc2025203. View

. Clinical characteristics and day-90 outcomes of 4244 critically ill adults with COVID-19: a prospective cohort study. Intensive Care Med. 2020; 47(1):60-73. PMC: 7674575. DOI: 10.1007/s00134-020-06294-x. View